Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Summary

Evaluate the Safety, Tolerability and Pharmacodynamics of Intravenous Administration of SHR-1707 In Patients with Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease.

Timeline

Start

2024-02-05

Primary completion

2026-01-30

Completion

2026-01-30

Outcome

Outcome not reported

Stopped (Business): “Based on the adjustment of the sponsor's R\&D strategy, it is decided to terminate this study in advance.”

Drugs

Indications